Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Opinion: Caution Required with COVID-19 Antibody/Immune Testing

By Harry W. Severance, MD, FACEP | on May 21, 2020 | 0 Comment
New Spin Opinion
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

It has been announced that rapid, point-of-care “antibody immune status” testing for the SARS-CoV-2 virus (which causes COVID-19) is now becoming generally available. This information has been promoted on various national news programs as a way to accelerate getting the population back to work and back to “normal,” and on-screen pundits are advocating rapid start-up of broad-scale national testing. This possibility has even been recently discussed by Anthony Fauci, MD, of the National Institute of Allergy and Infectious Diseases and the White House coronavirus committee.

You Might Also Like
  • Opinion: Emergency Physicians’ Reluctance to Implement Choosing Wisely Recommendations Brings Criticism
  • U.S. Companies, Labs Rush to Produce Blood Test for Coronavirus Immunity
  • Diabetes, Lung, and Heart Disease Common in U.S. COVID-19 Patient
Explore This Issue
ACEP Now: Vol 39 – No 05 – May 2020

The need to return society to a more normal situation and to return people to work is critical and becoming more pressing with each day. However, beyond questions surrounding the accuracy of such antibody testing in identifying those who truly present no transmission risk lies another, possibly yet unrecognized issue. I suggest that there may arise unintended consequences to rapid activation of programs utilizing antibody testing as a pathway to attempt to return society back to normal.

Since there are no vaccines available now or in the near future, the only way that one can currently achieve some level of immunity from COVID-19 is by contracting the disease. This fact could lead, with national “immune” testing, to a division within our society of “haves” and “have-nots.” The haves with their “document of immunity test” and purported lack of ability to transmit disease would be allowed to resume their normal lives, including no social distancing, return to work environments, etc. Those who are not tested by this pathway, or are tested and found to have not yet acquired COVID-19 (negative antibody/immunity test), could find themselves within the limbo of still being home-isolated, socially distanced, and, more important, not allowed to resume their normal lives, such as return to work, or severely limited in such options with all the financial ramifications.

If antibody/immune testing proves to be acceptably accurate, if it can be determined that most recovered persons will not suffer reactivated disease or become reinfected, and if test kits can be provided in the large quantities needed to perform blanket testing by states and locales, there are pressing motivations for such testing to be deployed by states and other large segments of society in the attempt to get people back to work, stabilize the economy, and attempt to reestablish normal life.

However, we see in the news and political discussions that there is steadily mounting pressure on and by federal, state, and local governmental decision-making bodies to move immediately forward on such antibody/immune testing even prior to fully understanding accuracy, length and breadth of immunity, and potential reinfection risk related to such testing. I want to bring an awareness to the fact that, beyond other questions and controversies surrounding antibody testing, there may be negative economic and social downstream consequences to large groups in our society with any rapid rush to blanket application of such testing as a pathway for reactivation of economy and society that need to be considered and addressed. 

Pages: 1 2 | Single Page

Topics: Antibody TestingcoronavirusCOVID-19Testing

Related

  • ACEP Member Uses ED, Military Training To Set Standards at FEMA

    August 11, 2025 - 0 Comment
  • Dr. Joe Sachs and “The Pitt” Redefine Public Health Education Through Storytelling

    July 3, 2025 - 0 Comment
  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Opinion: Caution Required with COVID-19 Antibody/Immune Testing”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603